Newsroom

As our brains age, small lesions begin to pop up in the bundles of white matter that carry messages between our neurons. The lesions can damage this white matter and lead to cognitive deficits. Now, researchers not only provide an explanation for the location of these lesions but also how they develop in the first place.

Hari Shroff, NIBIB, answers questions about his latest research into confocal microscopy. Source: AZO Life Sciences.

New MRI technology, developed by Siemens in collaboration with researchers at The Ohio State University College of Medicine and College of Engineering, will expand imaging access for patients with implanted medical devices, severe obesity or claustrophobia. The Ohio State University Wexner Medical Center is the first in the United States to install this recently FDA-approved full body MRI for patient care. Source: OSU.edu.

Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks. Researchers simulated an attack that falsified mammogram images, fooling both an AI breast cancer diagnosis model and human breast imaging radiologist experts.

Awards will support innovative technologies to help improve maternal health around the world.

NIH-funded researchers are investigating how to use smartwatches to predict clinical test results, which could potentially serve as an early warning signal for underlying health issues.

A team led by NIBIB scientists has developed hardware and software innovations to construct super-resolution, 3D confocal images of fine structures in living samples.

Washington University in St. Louis is joining a major international effort to advance data science, catalyze innovation and spur health discoveries across Africa. The program is supported by the National Institutes of Health’s (NIH) Common Fund, which will invest nearly $75 million over five years to fund the Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program. Source: Washington University in St. Louis

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue. NIH scientists and their collaborators say the information, published in Science Translational Medicine, could help predict severe and prolonged COVID-19 cases, particularly among high-risk people, and inform effective treatments. Read more at NIH.gov.